Precigen, Inc. (NASDAQ:PGEN – Get Free Report) Director Steven Frank purchased 400,000 shares of Precigen stock in a transaction on Monday, August 14th. The shares were purchased at an average cost of $1.72 per share, with a total value of $688,000.00. Following the transaction, the director now owns 882,358 shares in the company, valued at […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Steven Frank , Charles Schwab Investment Management Inc , Group Plc , Precigen Inc , Nasdaq , Cambridge Investment Research Advisors Inc , Citigroup Inc , Jpmorgan Chase Co , Get Free Report , Director Steven Frank , Trading Down , General Group Plc , Investment Research Advisors , Schwab Investment Management , Precigen Daily , Precigen , Nasdaq Pgen , Opgen , Medical , Insider Trading , Nsider Trades , Tocks ,